Related Experiment Video
Updated: Jun 6, 2026

07:17
Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
Published on: August 23, 2024
Arrayed primer extension technology simplifies mutation detection in Bardet-Biedl and Alström syndrome
Ines Pereiro1, Bethan E Hoskins, Jan D Marshall
1Departamento de Bioquímica, Genética e Inmunología, Facultad de Biología, Universidad de Vigo, Vigo, Spain.
European Journal of Human Genetics : EJHG
|December 16, 2010
Summary
A new genetic test efficiently screens for Bardet-Biedl syndrome (BBS) and Alström syndrome (ALMS), identifying mutations in over 40% of BBS families and 26% of ALMS families. This array also revealed complex genetic interactions in BBS.
Area of Science:
- Genetics
- Molecular Biology
- Rare Diseases
Background:
- Bardet-Biedl syndrome (BBS) and Alström syndrome (ALMS) are rare, multisystem genetic disorders.
- Both conditions are classified as ciliopathies and exhibit significant phenotypic variability and overlap.
- The genetic heterogeneity of BBS, with 14 known causal genes, complicates diagnostic mutational analysis.
Purpose of the Study:
- To evaluate the efficiency and cost-effectiveness of a newly developed BBS-ALMS array for mutation detection.
- To identify the frequency of detectable mutations in BBS and ALMS families using the array.
- To investigate potential complex genetic interactions, such as oligogenicity, in BBS and ALMS.
Main Methods:
- Development and application of the BBS-ALMS array for detecting known mutations in BBS and ALMS genes.
- Analysis of mutation detection rates in a cohort of BBS and ALMS families.
- Examination of allele segregation and mutation numbers within families.
Main Results:
- The BBS-ALMS array detected at least one mutation in 40.5% of BBS families and 26.7% of ALMS families.
- The array proved to be an efficient and cost-effective first-pass screening method.
- Two BBS families showed segregation of three BBS alleles, suggesting oligogenicity or modifier gene roles, while ALMS families did not exceed two mutations.
Conclusions:
- The BBS-ALMS array is a validated, efficient, and cost-effective tool for the initial genetic screening of Bardet-Biedl syndrome and Alström syndrome.
- The findings support the utility of this array in diagnosing ciliopathies.
- Evidence of complex genetic inheritance patterns, including oligogenicity, was observed in BBS, warranting further investigation.

